Jorge Pereira-Mota
Ordem, 4000270, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The Impact of BDNF, NTRK2, NGFR, CREB1, GSK3B, AKT, MAPK1, MTOR, PTEN, ARC, and SYN1 Genetic Polymorphisms in Antidepressant Treatment Response Phenotypes.
Journal: International journal of molecular sciences
Published: March 03, 2023
Predictors of poor 6-week outcome in a cohort of major depressive disorder patients treated with antidepressant medication: the role of entrapment.
Journal: Nordic journal of psychiatry
Published: July 11, 2020
Overcoming treatment-resistant major depressive disorder outside of the doctor´s office.
Journal: Psychiatry research
Published: March 07, 2019
Pets enhance antidepressant pharmacotherapy effects in patients with treatment resistant major depressive disorder.
Journal: Journal of psychiatric research
Published: February 08, 2018
IL6-174G > C genetic polymorphism influences antidepressant treatment outcome.
Journal: Nordic journal of psychiatry
Published: November 01, 2016
The role of IL18-607C>A and IL18-137G>C promoter polymorphisms in antidepressant treatment phenotypes: A preliminary report.
Journal: Neuroscience letters
Published: November 11, 2015
FAS -670A>G genetic polymorphism Is associated with Treatment Resistant Depression.
Journal: Journal of affective disorders
Published: February 10, 2015
Financial crisis increases the risk of depression relapse.
Journal: Journal of psychiatric research
Published: September 19, 2014
Common genetic polymorphisms in the ABCB1 gene are associated with risk of major depressive disorder in male Portuguese individuals.
Journal: Genetic testing and molecular biomarkers
Published: November 09, 2013
Facebook enhances antidepressant pharmacotherapy effects.
Journal: TheScientificWorldJournal
Published: August 28, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026